CC BY-NC-ND 4.0 · J Lab Physicians 2021; 13(03): 245-251
DOI: 10.1055/s-0041-1731111
Original Article

Strain Typing of Trichosporon asahii Clinical Isolates by Random Amplification of Polymorphic DNA (RAPD) Analysis

Thayanidhi Premamalini
1   Department of Microbiology, Sri Ramachandra Medical College & Research Institute, SRIHER, Porur, Chennai, Tamil Nadu, India
,
Vijayaraman Rajyoganandh
2   Department of Microbiology, Vels Institute of Science, Technology and Advanced Studies, Vels Institute, Chennai, Tamil Nadu, India
,
Ramaraj Vijayakumar
1   Department of Microbiology, Sri Ramachandra Medical College & Research Institute, SRIHER, Porur, Chennai, Tamil Nadu, India
,
Hemanth Veena
1   Department of Microbiology, Sri Ramachandra Medical College & Research Institute, SRIHER, Porur, Chennai, Tamil Nadu, India
,
Anupma Jyoti Kindo
1   Department of Microbiology, Sri Ramachandra Medical College & Research Institute, SRIHER, Porur, Chennai, Tamil Nadu, India
,
Rungmei SK Marak
3   Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
› Author Affiliations

Abstract

Objective The aim of this study was to identify and isolate Trichosporon asahii (T. asahii) from clinical samples and to assess the genetic relatedness of the most frequently isolated strains of T. asahii using random amplification of polymorphic DNA (RAPD) primers GAC-1 and M13.

Methods All the clinical samples that grew Trichosporon species, identified and confirmed by polymerase chain reaction (PCR) using Trichosporon genus-specific primers, were considered for the study. Confirmation of the species T. asahii was carried out by T. asahii-specific PCR. Fingerprinting of the most frequently isolated T. asahii isolates was carried out by RAPD using random primers GAC-1 and M13.

Results Among the 72 clinical isolates of Trichosporon sp. confirmed by Trichosporon-specific PCR, 65 were found to be T. asahii as identified by T. asahii-specific PCR. Fingerprinting of the 65 isolates confirmed as T. asahii using GAC-1 RAPD primer yielded 11 different patterns, whereas that of M13 primer produced only 5 patterns. The pattern I was found to be the most predominant type (29.2%) followed by pattern III (16.9%) by GAC-1 primer.

Conclusions This study being the first of its kind in India on strain typing of T. asahii isolates by adopting RAPD analysis throws light on genetic diversity among the T. asahii isolates from clinical samples. Fingerprinting by RAPD primer GAC-1 identified more heterogeneity among the T. asahii isolates than M13.



Publication History

Article published online:
02 July 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Rastogi VL, Nirwan PS. Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol 2007; 25 (01) 59-61
  • 2 Colombo AL, Padovan ACB, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev 2011; 24 (04) 682-700
  • 3 Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47 (04) 1074-1081
  • 4 Suzuki K, Nakase K, Kyo T. et al Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol 2010; 84 (05) 441-447
  • 5 Quindós G, Ruesga MT, Martín-Mazuelos E. et al In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol 2004; 21 (02) 63-69
  • 6 Nagai H, Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M. PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis. J Clin Microbiol 1999; 37 (03) 694-699
  • 7 Moretti-Branchini ML, Fukushima K, Schreiber AZ. et al Tanaka, R.; Miyaji M. Trichosporon species in bone marrow transplanted patients. Diagn Microbiol Infect Dis 2001; 39 (03) 161-164
  • 8 Pfaller MA. Epidemiology of fungal infections: the promise of molecular typing. Clin Infect Dis 1995; 20 (06) 1535-1539
  • 9 Sugita T, Makimura K, Nishikawa A, Uchida K, Yamaguchi H, Shinoda T. Partial sequences of large subunit ribosomal DNA of a new yeast species, Trichosporon domesticum and related species. Microbiol Immunol 1997; 41 (07) 571-573
  • 10 Sugita T, Nishikawa A, Shinoda T. Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J Clin Microbiol 1998; 36 (05) 1458-1460
  • 11 Sugita T, Nishikawa A. Molecular phylogenetic study of the basidiomycetous anamorphic yeast genus Trichosporon and related taxa based on small subunit ribosomal DNA sequences. Mycoscience 1998; 39: 7-13
  • 12 Sugita T, Nishikawa A, Shinoda T. Identification of Trichosporon asahii by PCR based on sequences of the internal transcribed spacer regions. J Clin Microbiol 1998; 36 (09) 2742-2744
  • 13 Pagnocca FC, Legaspe MFC, Rodrigues A. et al Yeasts isolated from a fungus-growing ant nest, including the description of Trichosporon chiarellii sp. nov., an anamorphic basidiomycetous yeast. Int J Syst Evol Microbiol 2010; 60 (Pt 6) 1454-1459
  • 14 Fagundes Júnior AA, Carvalho RT, Focaccia R. et al [Trichosporon asahii an emerging etiologic agent of fungal infection and colonization in heart failure patients in intensive care unit: case report and literature review]. Rev Bras Ter Intensiva 2008; 20 (01) 106-109
  • 15 Meyer MH, Letscher-Bru V, Waller J, Lutz P, Marcellin L, Herbrecht R. Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin Infect Dis 2002; 35 (02) e22-e25
  • 16 Sugita T, Nishikawa A, Ichikawa T, Ikeda R, Shinoda T. Isolation of Trichosporon asahii from environmental materials. Med Mycol 2000; 38 (01) 27-30
  • 17 Takamura S, Oono T, Kanzaki H, Arata J. Disseminated Trichosporonosis with Trichosporon asahii. Eur J Dermatol 1999; 9 (07) 577-579
  • 18 Toscano CM, Jarvis WR. Emerging issues in nosocomial fungal infections. Curr Infect Dis Rep 1999; 1 (04) 347-361
  • 19 Kalkanci A, Sugita T, Arikan S. et al Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 2010; 48 (01) 141-146
  • 20 Wolf DG, Falk R, Hacham M. et al Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39 (12) 4420-4425
  • 21 Lo Passo C, Pernice I, Celeste A, Perdichizzi G, Todaro-Luck F. Transmission of Trichosporon asahii oesophagitis by a contaminated endoscope. Mycoses 2001; 44 (1-2) 13-21
  • 22 Sugita T, Ichikawa T, Matsukura M. et al Genetic diversity and biochemical characteristics of Trichosporon asahii isolated from clinical specimens, houses of patients with summer-type-hypersensitivity pneumonitis, and environmental materials. J Clin Microbiol 2001; 39 (07) 2405-2411
  • 23 Carnovale S, Lorenzo J, Kaufman S, Finquelievich J, Guelfand L. Genotypic study of strains belonging to the genus Trichosporon. Med Mycol 2007; 45 (01) 51-56
  • 24 Lyman CA, Devi SJ, Nathanson J, Frasch CE, Pizzo PA, Walsh TJ. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995; 33 (01) 126-130
  • 25 Magalhães AR, Mondino SS, Silva Md, Nishikawa MM. Morphological and biochemical characterization of the aetiological agents of white piedra. Mem Inst Oswaldo Cruz 2008; 103 (08) 786-790
  • 26 Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nippon Ishinkin Gakkai Zasshi 2006; 47 (03) 225-229
  • 27 Vijayakumar R, Giri S, Kindo AJ. Molecular species identification of Candida from blood samples of intensive care unit patients by polymerase chain reaction - restricted fragment length polymorphism. J Lab Physicians 2012; 4 (01) 1-4
  • 28 Premamalini T, Rajyoganandh SV, Vijayakumar R. Kindo AJ, Marak Rungmei SKM. Trichosporonosis - an association with clinical factors and its outcome. Int J Microbiol Res 2018; 10 (03) 1078-1082
  • 29 Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215 (03) 403-410
  • 30 Ahmad S, Al-Mahmeed M, Khan ZU. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 2005; 54 (Pt 7) 639-646
  • 31 Ahmad S, Khan Z, Mustafa AS, Khan ZU. Epidemiology of Candida colonization in an intensive care unit of a teaching hospital in Kuwait. Med Mycol 2003; 41 (06) 487-493
  • 32 do Espírito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH. Molecular identification, genotyping, phenotyping, and antifungal susceptibilities of medically important Trichosporon, Apiotrichum, and Cutaneotrichosporon species. Mycopathologia 2020; 185 (02) 307-317
  • 33 Fujita SI, Senda Y, Nakaguchi S, Hashimoto T. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol 2001; 39 (10) 3617-3622
  • 34 Li HM, Du HT, Liu W, Wan Z, Li RY. Microbiological characteristics of medically important Trichosporon species. Mycopathologia 2005; 160 (03) 217-225
  • 35 Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E. et al Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49 (10) 4026-4034
  • 36 Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16 (04) 915-933 vi–vii
  • 37 Sellami H, Trabelsi H, Neji S. et al First genotype identification of Trichosporon asahii in Sfax, Tunisia. J Med Microbiol 2017; 66 (04) 397-401
  • 38 Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40 (05) 1826-1830
  • 39 Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A. et al. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis. 2007; 58: 435-440
  • 40 Mekha N, Sugita T, Ikeda R. et al Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 2010; 169 (01) 67-70
  • 41 Rastogi V, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A, Chakrabarti A. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India. Mycoses 2016; 59 (08) 528-534